Emcure Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

EMCURE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.1%1-day move

₹1548.00

prior close

₹1560.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.2-0.2-0.2+1.1+3.6+2.9+5.2+6.0+8.6+11.6+7.0+11.1+19.2

Up moveDown movePending

AI summary

Emcure Pharmaceuticals has filed a routine compliance certificate confirming that its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, properly handled all dematerialization requests during Q4 FY26 (January-March 2026). The RTA confirmed that securities received for dematerialization were processed and listed on NSE and BSE within prescribed timelines. The filing also verifies that physical share certificates were mutilated and cancelled, and depository names were substituted in the register of members as required under SEBI regulations.

Likely market impact

This is a standard regulatory compliance filing with no direct impact on the company's financials or shareholding. It provides routine assurance that the dematerialization process was conducted properly and within timelines, which is a regular quarterly requirement for all listed companies.